Jarmila H.
- Country
- Czechia
- Department
- Dept. of Ophthalmology
Research Overview
- Evaluation of Atropine Sulfate Monohydrate Eye Drops in Myopia Progression in Pediatric Patients: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Izokibep in Patients with Non-infectious Intermediate, Posterior, or Pan-uveitis: A Phase 2b Randomized Controlled Trial
- Evaluation of Escherichia coli Strain Nissle 1917 in the Management of Autoimmune Non-Infectious Uveitis: A 12-Month Follow-Up Study
Data & Insights
Has run more than one trial at 18 of 57 partner sites.
Specializations
Ophthalmological Conditions
This investigator specializes in treating various forms of uveitis and related eye conditions, with particular emphasis on non-infectious uveitis including intermediate, posterior, and pan-uveitis manifestations.
- Non-infectious Uveitis Management
- Uveitic Macular Edema Treatment
- Pediatric Myopia Control
Their work encompasses both adult and pediatric ophthalmological interventions.
Therapeutic Approaches
The investigator explores diverse treatment modalities including intravitreal therapeutics and innovative biological treatments. Their research extends to novel applications of probiotics in ocular conditions.
- Intravitreal Drug Administration
- Probiotic Therapy Applications
- Targeted Immunological Treatments
Focus includes both conventional and emerging therapeutic approaches for ocular inflammation.
Clinical Focus Areas
The investigator concentrates on treating macular conditions and inflammatory eye disorders, with specific attention to autoimmune ocular manifestations.
- Macular Edema Management
- Inflammatory Eye Disease
- Vision Preservation Strategies
Their work encompasses long-term management of chronic ocular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.